No photo of Emmi Joensuu
  • PL 63 (Haartmaninkatu 8)




Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3111 Biomedicine
  • 1182 Biochemistry, cell and molecular biology
  • 1184 Genetics, developmental biology, physiology

International and National Collaboration Publications and projects within past five years.


Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

Li, C., Rezov, V., Joensuu, E., Vartiainen, V., Rönty, M., Yin, M., Myllärniemi, M. & Koli, K., 3 Jul 2018, In : Scientific Reports. 8, 14 p., 10070.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Pirfenidoni potentiaalisena adjuvanttiterapiana mesoteliooman hoidossa

Joensuu, E. I., 26 Jul 2018, In : BestPractice: Onkologia / hematologia.

Research output: Contribution to journalArticleProfessional

Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice

Vartiainen, V., Raula, J., Bimbo, L. M., Viinamäki, J., Backman, J. T., Ugur, N., Kauppinen, E., Sutinen, E., Joensuu, E., Koli, K. & Myllärniemi, M., 10 Jun 2018, In : International Journal of Pharmaceutics. 544, 1, p. 121-128 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Epigenetic alterations in sporadic and familial cancers

Joensuu, E., 2015, Helsinki: University of Helsinki. 92 p.

Research output: ThesisDoctoral ThesisCollection of Articles


  • 1 Supervision of other thesis (Master's, Licentiate)

Supervision of Master's thesis

Emmi Joensuu (Supervisor)
1 May 201711 Jun 2018

Activity: Examination typesSupervision of other thesis (Master's, Licentiate)